Abstract
To learn about the relevance of epidemiology in paediatric rheumatology (PR)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fink CW. Proposal for the development of classification criteria for idiopathic arthritis of childhood [see comments] [published erratum appears in J Rheumatol 1995 Nov;22 (11):2195]. J Rheumatol. 1995;22:1566–9.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
Andersson Gare B, Fasth A. Epidemiology of juvenile chronic arthritis in south-western Sweden: a 5-year prospective population study. Pediatrics. 1992;90:950–8.
Mielants H, Veys EM, Maertens M, et al. Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium. Clin Exp Rheumatol. 1993;11:563–7.
Oen K, Fast M, Postl B. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975–92: cycles in incidence. J Rheumatol. 1995;22:745–50.
Arguedas O, Porras O, Fasth A. Juvenile chronic arthritis in Costa Rica. A pilot referral study. Clin Exp Rheumatol. 1995;13:119–23.
Malleson P, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol. 1996;23:1981–7.
Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Dermatol. 1995;34:732–6.
Peterson LS, Mason T, Nelson AM, O’Fallon WM, Gabriel SE. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960–1993. Is the epidemiology changing? Arthritis Rheum. 1996;39:1385–90.
Kaipiainen-Seppanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980–1990. Clin Exp Rheumatol. 1996;14:441–4.
Manners PJ, Diepeveen DA. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics. 1996;98:84–90.
Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn. 1997;39:242–4.
Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25:2445–9.
Moe N, Rygg M. Epidemiology of juvenile chronic arthritis in northern Norway: a ten- year retrospective study. Clin Exp Rheumatol. 1998;16:99–101.
Kiessling U, Doring E, Listing J, et al. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980–88. J Rheumatol. 1998;25:1837–43.
Arguedas O, Fasth A, Andersson-Gare B, Porras O. Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2 year prospective study. J Rheumatol. 1998;25:1844–50.
Huang J-L, Yao T-C, See L-C. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Pediatr Rheumatol. 2004;22:776–80.
Hanova P, Pavelka K, Dostal C, et al. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002–2003. Clin Exp Rheumatol. 2006;24:499–507.
Danner S, Sordet C, Terzic J, et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol. 2006;33:1377–81.
Kurahara D, Grandinetti L, Fujii L, Tokuda A, et al. Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol. 2007;34:425–9.
Martinez-Minguel L, Fernandez Menendez J, Soli Sanchez G, et al. Epidemiological study of juvenile idiopathic arthritis in the last sixteen years in Asturias (Spain). An Pediatr. 2007;66:24–30.
Solau-Gervais E, Robin C, Gambert C, et al. Prevalence and distribution of juvenile idiopathic arthritis in a region of Western France. Joint Bone Spine. 2010;77:47–9.
Modesto C, Anton J, Rodriguez B, et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol. 2010;39:472–9.
Azam S, Dipti T, Rahman S. Prevalence and clinical pattern of juvenile idiopathic arthritis in a semi-urban area of Bangladesh. Int J Rheum Dis. 2012;15:116–20.
Harrold L, Salman C, Shoor S, et al. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996–2009. J Rheumatol. 2013;40:1218–25.
Abujam B, Mishra R, Aggarwal A. Prevalence of musculoskeletal complaints and juvenile idiopathic arthritis in children from a developing country: a school-based study. Int J Rheum Dis. 2014;17:256–60.
Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112–7.
Manners PJ. Delay in diagnosis of juvenile arthritis. Med J Aust. 1999;171:367–9.
Andersson-Gare B. Juvenile arthritis – who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol. 1999;17:367–74.
Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis. 2012;71:1437–9.
Saurenmann R, Rose J, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 2007;56(6):1974–84.
Gare BA. Epidemiology of rheumatic disease in children. Curr Opin Rheumatol. 1996;8:449–54.
Martini A. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? J Rheumatol. 2003;30:1900–3.
Ferrell E, Ponder L, Minor L, et al. Limitations in the classification of childhood-onset rheumatoid arthritis. J Rheumatol. 2014;41:547–53.
van den Broek T, Hoppenreijs E, Meerding J, et al. Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis. Ann Rheum Dis. 2015;74:470–2.
Manners PJ, Lesslie J, Speldewinde D, Tunbridge D. Classification of juvenile idiopathic arthritis: should family history be included in the criteria? J Rheumatol. 2003;30:1857–63.
D’Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosus. Lancet. 2007;369:587–96.
Danchenko N, Satia LA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15:308–18.
Hiraki LT, Menseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman E. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol. 2009;36:2539–46.
Lau C, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus. 2006;15:715–9.
McCarty DJ, Manzi S, Medsger T, Ramsey-Goldman R, LaPorte R, Kwoh C. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum. 1995;38:1260–70.
Hom G, Graham G, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900–9.
Dozmorov M, Wren J, Alarcon-Riquelme M. Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes. Epigenetics Off J DNA Methylation Soc. 2014;9:276–85.
Mendez E, Lipton R, Ramsey-Goldman R, et al. US Incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Disease Registry. Arthritis Rheum. 2003;49:300–5.
Cervera R, Piette J, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–27.
Myones B. Update on antiphospholipid syndrome in children. Curr Rheumatol Rep. 2011;13:86–9.
Gunnarsson R, Gran JT, et al. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70:1047–51.
Burdt M, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.
Michels H. Course of mixed connective tissue disease in children. Ann Med. 1997;29:359–64.
Tizard E, Hamilton-Ayres M. Henoch-Schonlein purpura. Arch Dis Child Educ Pract Ed. 2007;93:1–8.
Gardner-Medwin JMM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schonlein Purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197–202.
Mason W, Takahashi M. Kawasaki syndrome. Clin Infect Dis. 1999;28:169–85.
Yim D, Curtis N, Cheung M, Burgner D. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J Paediatr Child Health. 2012;49:704–8.
Chang C-J, Kuo H-C, Chang J-S, et al. Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One. 2013;8:e72037.
Gedalia A. Kawasaki disease: 40 years after the original report. Curr Rheumatol Rep. 2007;9:336–41.
Holman R, Curns A, Belay E, et al. Kawasaki syndrome hospitalisation in the United States. Pediatrics. 2003;112:495–501.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Manners, P.J. (2017). Epidemiology of Pediatric Rheumatic Diseases. In: Sawhney, S., Aggarwal, A. (eds) Pediatric Rheumatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-1750-6_5
Download citation
DOI: https://doi.org/10.1007/978-981-10-1750-6_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1749-0
Online ISBN: 978-981-10-1750-6
eBook Packages: MedicineMedicine (R0)